Newmark has completed the recapitalization of 300 Third Street, a six-story 131,963-square-foot Class A laboratory/office asset in Cambridge, MA. The transaction is the seller’s fourth recapitalization since 2019 overseen by Newmark for its assets along Kendall Square’s Binney Street corridor, with a total consideration of $3.2 billion.

Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark represented the seller. William Sleeper of Newmark provided financial analysis support.

300 Third Street’s 129,424-square-foot laboratory/office component is fully leased to Alnylam, a pharmaceutical company that is recognized for developing the world’s first and only RNAi therapeutics. Its 2,539-square-foot retail component is fully leased to Fuji at Kendall, an upscale sushi restaurant. The property also features a 139-space parking garage.

300 Third Street is situated within a five-minute walk of the MBTA Red Line’s Kendall/MIT subway station, which facilitates access across the rest of Cambridge and Downtown Boston.